ctDNA can detect minimal residual disease in curative treated non-small cell lung cancer patients using a tumor agnostic approach

Rosenlund, L., Guldbrandsen, K., Ahlborn, L. B., Bloch, M., Skougaard, K., Albrecht-Beste, E., Nellemann, H. M., Krakauer, M., Gørtz, P. M., Fledelius, J., Nielsen, A. L., Holdgaard, P. C., Nielsen, S. S., Grüner, J. M., Højsgaard, A., Petersen, R. H., Møller, L. B., Dahl, M., Frank, M. S. & Ehlers, J. H. & 23 others, Saghir, Z., Pøhl, M., Borissova, S., Land, L. H., Kristiansen, C., McCulloch, T., Mortensen, L. S., Christophersen, M. S., Hilberg, O., Rasmussen, T. L., Simonsen Schwaner, S. H., Laursen, C. B., Bodtger, U., Lonsdale, M. N., Meyer, C. N., Gerke, O., Mortensen, J., Rasmussen, T. R., Hjorthaug, K., Larsen, K. R., Meldgaard, P., Fischer, B. M. & Sorensen, B. S., 2025, In: Lung Cancer. 203, 12 p., 108528.

Research output: Contribution to journal › Journal article › Research › peer-review

Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Lung Cancer After Completion of Curative treatment (SUPE_R): A Randomized Controlled Trial

Guldbrandsen, K. F., Bloch, M., Skougaard, K., Ahlborn, L. B., Jakobsen, E., Højsgaard, A., Petersen, R. H., Møller, L. B., Dahl, M., Sorensen, B. S., Frank, M. S., Ehlers, J. H., Krakauer, M., Gørtz, P. M., Albrecht-Beste, E., Grüner, J. M., Saghir, Z., Fledelius, J., Nielsen, A. L. & Holdgaard, P. C. & 22 others, Nielsen, S. S., Pøhl, M., Borissova, S., Land, L. H., Kristiansen, C., McCulloch, T., Mortensen, L. S., Nellemann, H. M., Christophersen, M. S., Hilberg, O., Rasmussen, T. L., Schwaner, S. H. S., Laursen, C. B., Bodtger, U., Sopina, L., Lonsdale, M. N., Meyer, C. N., Gerke, O., Mortensen, J., Rasmussen, T. R., Fischer, B. M. & SUPE_R Study Group, 2025, (E-pub ahead of print) In: Journal of Thoracic Oncology.

Research output: Contribution to journal › Journal article › Research › peer-review